Jacob Chacko, M.D.
About Jacob Chacko, M.D.
Jacob Chacko is the President, CEO, and a Board Member with a distinguished academic and professional background, including roles at McKinsey, TPG Capital, and Ignyta.
Jacob Chacko: Current Position and Roles
Jacob Chacko currently holds the positions of President, Chief Executive Officer, and Board Member. He plays a leading role in strategic decision-making and overall management. His responsibilities include overseeing company operations, steering executive leadership, and driving corporate growth and development.
Jacob Chacko's Education and Academic Honors
Jacob Chacko received his MD with AOA honors from UCLA. He also earned an MBA with Distinction from Harvard Business School, where he served as Co-President of the Student Body. Additionally, Jacob holds a MSc from Oxford University, where he studied as a Marshall Scholar. He graduated as the University Valedictorian from the University of Southern California, highlighting his academic excellence across diverse fields.
Jacob Chacko's Professional Background
Jacob Chacko has a substantial professional background that includes serving as CFO of Ignyta, a role where he oversaw the company until its acquisition by Roche. At TPG Capital, Jacob led teams in acquisitions valued over $10 billion. Additionally, he worked as a consultant for healthcare clients at McKinsey & Company, leveraging his expertise to drive strategic projects and initiatives in the healthcare industry.
Jacob Chacko: Board Memberships and Leadership Roles
Jacob Chacko serves on the board of directors of 4D Molecular Therapeutics and chairs the board of directors of Bright Peak Therapeutics. He also chairs the Western Regional Selection Committee for the Marshall Scholarship. Jacob has previously served on the boards of several companies, including Turning Point Therapeutics and Bonti, and acted as a board observer for companies like Par Pharmaceutical and IMS Health.